Residual plasma in red blood cells and transfusion-related acute lung injury

Transfusion

Volumn 54, Issue 10, 2014, Pages 2425-2430

  Weber, Litchia L ^a   Roberts, Laura D ^b   Sweeney, Joseph D ^a,b  

^a ROGER WILLIAMS MEDICAL CENTER   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DR1 ANTIGEN; HLA DR11 ANTIGEN; HLA DR4 ANTIGEN; HLA DR53 ANTIGEN; HLA DR8 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BIOASSAY; BLOOD DONOR; BLOOD STORAGE; BRAIN METASTASIS; CRYOPRECIPITATE; DYSPNEA; ERYTHEMA; ERYTHROCYTE TRANSFUSION; EXTUBATION; FATIGUE; FEMALE; FLUORESCENT BEAD ASSAY; HEMATOCRIT; HLA SYSTEM; HUMAN; HYPOTENSION; LUNG ADENOCARCINOMA; LUNG EDEMA; MALE; MIDDLE AGED; OXYGEN SATURATION; PLASMA; PLASMA VOLUME; PREVALENCE; RECIPIENT; RESUSCITATION; SPLEEN RUPTURE; SPLENECTOMY; THORAX RADIOGRAPHY; TRACHEOSTOMY; TRANSFUSION RELATED ACUTE LUNG INJURY; WEAKNESS; ACUTE LUNG INJURY; CASE REPORT; IMMUNOLOGY; PLASMAPHERESIS; STANDARDS;

ACUTE LUNG INJURY; AGED; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMA; PLASMAPHERESIS;

EID: 84908089595     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12662     Document Type: Article

References (28)

1. Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion. 2008-2012. 2013. [cited 2014 Mar 28]. Available from: http://www.fda.gov
2. Win N, Chapman CE, Bowles KM, et al. How much residual plasma may cause TRALI? Transfus Med 2008; 18: 276-280.
3. Canadian Blood Services. Circular of information for the use of human blood components. Ottawa, Ontario, Canada. 2011 [cited 2014 Mar 28]. Available from: http://www.blood.ca
4. Cardigan R, Maclennan S,. Allogeneic blood components. Transfus Altern Transfus Med 2008; 10: 92-101.
5. American Association of Blood Banks, American Red Cross, America's Blood Centers, and Armed Services Blood Program. Circular of information for the use of human blood components. 2013. [cited 2014 Mar 28]. Available from: http://www.fda.com.
6. Heaton AL, Rebulla P, Pappalettera M, et al. A comparative analysis of different methods for routine blood component preparation. Transfus Med Rev 1997; 11: 116-129.
7. Popovsky MA, Abel MD, Moore SB,. Transfusion-related acute lung injury associated with passive transfer of anti-leukocyte antibodies. Am Rev Respir Dis 1983; 128: 185-189.
8. Popovsky MA, Moor SB,. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25: 573-577.
9. Popovsky MA, Chaplin HC Jr, Moore SB,. Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion 1992; 32: 589-592.
10. Wallis JP,. Transfusion-related acute lung injury under-diagnosed and under-reported. Br J Anaesth 2003; 90: 573-576.
11. Kopko PM, Marshall CS, MacKenzie MR, et al. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002; 287: 1968-1971.
12. Chapman CE, Stainsby D, Jones H, et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009; 49: 440-452.
13. Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009; 49: 1825-1835.
14. Funk M, Guenay S, Lohmann A, et al. Benefit of transfusion-related acute lung injury risk-minimization measures-German haemovigilance data (2006-2010). Vox Sang 2012; 102: 317-323.
15. Ozier Y, Muller J, Mertes P, et al. Transfusion-related acute lung injury: reports to the French Hemovigilance Network, 2007 through 2008. Transfusion 2011; 51: 2102-2110.
16. Middleburg RA, Porcheijn L, Lardy N, et al. Prevalence of leucocyte antibodies in the Dutch donor population. Vox Sang 2011; 100: 327-335.
17. Sigle JP, Thierbach J, Infante L, et al. Anti-leukocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention. Vox Sang 2013; 105: 244-252.
18. Morales-Buenrostro L, Terasaki P, Marino-Vasquez L, et al. "Natural" human leukocyte antigen antibodies found in non-alloimmunized healthy males. Transplantation 2008; 86: 1111-1115.
19. Hashimoto S, Nakajima F, Kamada H, et al. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury. Transfusion 2010; 50: 2582-2591.
20. Kakaiya R,. The influence of donor antibody strength and recipient antigens on transfusion-related acute lung injury development. Transfusion 2010; 50: 2533-2535.
21. Odent-Malaure H, Quainon F, Ruyer-Dumontier R, et al. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations. Clin Dev Immunol 2005; 12: 243-248.
22. Vlaar AP, Hofstra JJ, Determann RM, et al. The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. Blood 2011; 117: 4218-4225.
23. Benjamin RJ,. Tracking TRALI in target populations. Blood 2011; 117: 4163-4164.
24. Endres RO, Kleinman SH, Carrick DM, et al. Identification of specificities of antibodies against human leukocyte antigens in blood donors. Transfusion 2010; 50: 1749-1760.
25. Gajic O, Rana R, Mendez JL, et al. Acute lung injury after blood transfusion in mechanically ventilated patients. Transfusion 2004; 44: 1468-1474.
26. Nishimura M, Hashimoto S, Takanashi M, et al. Role of anti-human leucocyte antigen class II antibody and monocytes in development of transfusion-related acute lung injury. Transfus Med 2007; 17: 129-134.
27. Lieberman L, Petraszko T, Yi QL, et al. Transfusion-related lung injury in children: a case series and review of the literature. Transfusion 2014; 54: 57-64.
28. Narick C, Truilzi DJ, Yazer MH,. Transfusion associated circulatory overload after plasma transfusion. Transfusion 2012; 52: 160-165.